dipyridamole has been researched along with Arteriosclerosis in 104 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Using the key terms acute coronary syndrome, atherothrombosis, ischemic stroke, myocardial infarction, MI, peripheral arterial disease, TIA, transient ischemic attack, unstable angina,aspirin,ticlopidine,dipyridamole, and clopidogrel, we searched the MEDLINE database as well as the trial register of the Cochrane Groups to identify studies published from 1960 to August 2004." | 4.82 | Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. ( Anand, SS; Tran, H, 2004) |
| "We evaluated the usefulness of dipyridamole-thallium imaging for the detection of ischaemic heart disease in 257 patients with atherosclerotic vascular disease (80 patients with arteriosclerosis obliterans, 81 patients with aneurysm of the abdominal aorta, 60 patients with aneurysm of the thoracic aorta and 36 patients with dissecting aortic aneurysm)." | 3.69 | Usefulness of dipyridamole-thallium imaging in 257 patients with atherosclerotic vascular disease. ( Hayashida, K; Ishida, Y; Nishimura, T; Shimonagata, T; Toyama, T; Uehara, T, 1995) |
| "We evaluated the usefulness of dipyridamole 201Tl myocardial scintigraphy (DS) for detecting myocardial ischemia in 18 candidate for vascular surgery." | 3.68 | [The usefulness of dipyridamole stress myocardial scintigram as a preoperative test for detecting ischemic heart disease before vascular surgery]. ( Ando, H; Ando, S; Ashihara, T; Fujinaga, Y; Fukuoka, T; Fukuyama, T; Higuchi, Y; Mitsuoka, W; Tagawa, H, 1992) |
| "Only aspirin has been evaluated in the setting of primary prevention and it seems to be ineffective in preventing cerebral infarction." | 2.68 | [Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors]. ( Canaple, S; Rosa, A, 1996) |
| "For this update the Cochrane Peripheral Vascular Diseases Group Trials Search Co-ordinator searched the Specialised Register (last searched June 2014) and the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Issue 5)." | 2.52 | Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. ( Acosta, S; Bedenis, R; Lethaby, A; Maxwell, H; Prins, MH, 2015) |
| "The mean value of the thrombus area in the dilazep group was 60% smaller and the distribution pattern of the thrombus by size was found to be composed of smaller thrombi than those of the control group." | 1.28 | Thrombus formation on the aorta injured by angioplasty and its prevention with dilazep in atherosclerotic rabbits. ( Asanuma, A; Fujii, M; Nobuyoshi, M; Takimoto, M; Tanaka, M, 1989) |
| "Accelerated graft arteriosclerosis is a major cause of death in human heart transplantation." | 1.26 | Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. ( Billingham, ME; Harrison, DC; Jamieson, SW; Lurie, KG; Reitz, BA, 1981) |
| "Dipyridamole treatment lowered basal as well as PGI2-induced cAMP levels below values seen in platelets from normal rabbits, but the stimulation by PGI2 relative to basal cAMP levels was not affected or even increased by dipyridamole treatment." | 1.26 | Effects of dipyridamole in experimental atherosclerosis. Action on PGI2, platelet aggregation and atherosclerotic plaque formation. ( Dembińska-Kièć, A; Rücker, W; Schönhöfer, PS, 1979) |
| "Treatment with dipyridamole (DPD) for 4 weeks resulted in a reduction of the ATP content in platelets and arterial tissue from atherosclerotic rabbits to values seen in normal animals." | 1.26 | Effects of dipyridamole in vivo on ATP and cAMP content in platelets and arterial walls and on atherosclerotic plaque formation. ( Dembinska-Kiec, A; Rücker, W; Schönhöfer, PS, 1979) |
| " A heart rate in the 50s does not preclude an increase in the dosage of propranolol when necessary." | 1.26 | Pathophysiology and medical management of angina pectoris. ( Brest, AN; Duca, PR; Gottlieb, RS, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 81 (77.88) | 18.7374 |
| 1990's | 14 (13.46) | 18.2507 |
| 2000's | 8 (7.69) | 29.6817 |
| 2010's | 1 (0.96) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedenis, R | 1 |
| Lethaby, A | 1 |
| Maxwell, H | 1 |
| Acosta, S | 1 |
| Prins, MH | 1 |
| Lecompte, T | 1 |
| Rao, U | 1 |
| Weston, C | 1 |
| Tran, H | 1 |
| Anand, SS | 1 |
| Zhao, L | 1 |
| Gray, L | 1 |
| Leonardi-Bee, J | 1 |
| Weaver, CS | 1 |
| Heptinstall, S | 1 |
| Bath, PM | 1 |
| Fontana, P | 1 |
| Jamieson, DG | 1 |
| Lorenzen, ND | 1 |
| Eldrup, N | 1 |
| Laustsen, J | 1 |
| Loew, D | 2 |
| Breddin, K | 1 |
| Uberla, K | 1 |
| Murray, PD | 1 |
| Garnic, JD | 1 |
| Bettmann, MA | 1 |
| Branson, HE | 1 |
| Endo, Y | 1 |
| Fagin, AR | 1 |
| Schlutz, M | 1 |
| López-Campos, JL | 1 |
| Piñero, J | 1 |
| Lasierra, J | 2 |
| Navas, P | 1 |
| Moreno, J | 1 |
| Cobo, R | 1 |
| Bousser, MG | 2 |
| Eschwège, E | 1 |
| Haguenau, M | 1 |
| Lefauconnier, JM | 1 |
| Thibult, N | 1 |
| Touboul, D | 1 |
| Touboul, PJ | 1 |
| Bollinger, A | 1 |
| Biland, L | 1 |
| Brunner, U | 1 |
| Kappert, A | 1 |
| Krähenbühl, B | 1 |
| Mahler, F | 1 |
| Monti, M | 1 |
| Nachbur, B | 1 |
| Schneider, E | 1 |
| Widmer, LK | 1 |
| Faxon, DP | 2 |
| Sanborn, TA | 1 |
| Haudenschild, CC | 2 |
| Ryan, TJ | 2 |
| Mehta, J | 3 |
| Eichner, ER | 1 |
| Solvay, H | 3 |
| Kahn, M | 3 |
| Selosse, P | 1 |
| Carlier, J | 1 |
| Cloarec, M | 3 |
| Delwiche, JP | 1 |
| Fenollar, J | 1 |
| Bastida, E | 1 |
| Pyrig, LA | 1 |
| Petrun, NM | 1 |
| Nikulina, GG | 1 |
| Gorelova, NR | 1 |
| Viinikka, L | 1 |
| Salokannel, J | 1 |
| Ylikorkala, O | 1 |
| Hess, H | 1 |
| Mustard, JF | 3 |
| Packham, MA | 3 |
| Kinlough-Rathbone, RL | 3 |
| Mehta, P | 1 |
| Castaigne, A | 1 |
| Benghozi, R | 1 |
| Bienvenu, MP | 1 |
| Bonchek, LI | 1 |
| Boerboom, LE | 1 |
| Olinger, GN | 1 |
| Pepper, JR | 1 |
| Munns, J | 1 |
| Hutchinson, L | 1 |
| Kissebah, AH | 1 |
| Fuster, V | 2 |
| Chesebro, JH | 2 |
| Lurie, KG | 1 |
| Billingham, ME | 1 |
| Jamieson, SW | 1 |
| Harrison, DC | 1 |
| Reitz, BA | 1 |
| Sloan, RW | 1 |
| Mehta, JL | 1 |
| Verdecchia, P | 1 |
| Malinow, MR | 1 |
| Turczyński, B | 1 |
| Machalski, M | 1 |
| Maślankiewicz, A | 1 |
| Kossmann, S | 1 |
| Szwed, Z | 1 |
| Koster, JK | 1 |
| Tryka, AF | 1 |
| H'Doubler, P | 1 |
| Collins, JJ | 1 |
| Paredero Del Bosque Martin, V | 1 |
| Akopov, SE | 2 |
| Gabrielian, ES | 2 |
| Sarin, S | 1 |
| Shami, SK | 1 |
| Cheatle, TR | 1 |
| Bearn, P | 1 |
| Scurr, JH | 1 |
| Coleridge Smith, PD | 1 |
| Carrel, T | 1 |
| Zünd, G | 1 |
| Jenni, R | 1 |
| Turina, M | 1 |
| Toyama, T | 2 |
| Uehara, T | 2 |
| Shimonagata, T | 2 |
| Hayashida, K | 2 |
| Ishida, Y | 1 |
| Nishimura, T | 2 |
| Rosa, A | 1 |
| Canaple, S | 1 |
| Gould, KL | 1 |
| Nakagawa, Y | 1 |
| Nakagawa, K | 1 |
| Sdringola, S | 1 |
| Hess, MJ | 1 |
| Haynie, M | 1 |
| Parker, N | 1 |
| Mullani, N | 1 |
| Kirkeeide, R | 1 |
| Jobin, F | 1 |
| Lee, RJ | 2 |
| Baky, SH | 2 |
| Hollander, W | 1 |
| Kirkpatrick, B | 1 |
| Paddock, J | 1 |
| Colombo, M | 1 |
| Nagraj, S | 1 |
| Prusty, S | 1 |
| Dembińska-Kièć, A | 2 |
| Rücker, W | 2 |
| Schönhöfer, PS | 2 |
| Friedman, RJ | 1 |
| Burns, ER | 1 |
| Zicot, M | 1 |
| Harker, LA | 8 |
| Verstraete, M | 1 |
| Strano, A | 1 |
| Novo, S | 1 |
| McGiff, JC | 1 |
| Gottlieb, RS | 1 |
| Duca, PR | 1 |
| Brest, AN | 1 |
| Parenti, M | 1 |
| Pasquali, R | 1 |
| Bianchi, V | 1 |
| Barillari, C | 1 |
| Vezzadini, P | 1 |
| Rossi, EC | 1 |
| Pokrovskii, AV | 1 |
| Aleksandrova, NP | 1 |
| Kovalenko, VI | 1 |
| Deykin, D | 1 |
| Hirsh, J | 2 |
| Gent, M | 2 |
| Genton, E | 2 |
| Ross, R | 2 |
| Slichter, SJ | 2 |
| Scott, CR | 1 |
| Glomset, J | 1 |
| Moore, S | 1 |
| Balelli, LA | 1 |
| Sandborn, T | 1 |
| Haudenschild, C | 1 |
| Valeri, R | 1 |
| Ando, S | 1 |
| Ashihara, T | 1 |
| Ando, H | 1 |
| Mitsuoka, W | 1 |
| Tagawa, H | 1 |
| Higuchi, Y | 1 |
| Fukuoka, T | 1 |
| Fukuyama, T | 1 |
| Fujinaga, Y | 1 |
| Fabris, F | 1 |
| Steffan, A | 1 |
| Randi, ML | 1 |
| Avruscio, GP | 1 |
| Cordiano, I | 1 |
| Girolami, A | 1 |
| Hamada, S | 1 |
| Hirose, Y | 1 |
| Kaminaga, T | 1 |
| Ito, A | 1 |
| Nonogi, H | 1 |
| Mares, M | 1 |
| Sogaro, F | 1 |
| Scomparin, MA | 1 |
| Boeri, G | 1 |
| Cella, G | 1 |
| Rudofsky, G | 2 |
| Ranft, J | 1 |
| Hirche, H | 1 |
| Mittal, SR | 1 |
| Mathur, AK | 1 |
| Tandon, R | 1 |
| Gonzalez, J | 1 |
| Aza, MJ | 1 |
| Melon, J | 1 |
| Vazquez, E | 1 |
| Collado, PS | 1 |
| Castellarnau, C | 1 |
| Rutllant, M | 1 |
| Nobuyoshi, M | 1 |
| Tanaka, M | 1 |
| Fujii, M | 1 |
| Asanuma, A | 1 |
| Takimoto, M | 1 |
| Vitoux, JF | 1 |
| Languillat, N | 1 |
| du Peloux, L | 1 |
| Lévy, M | 1 |
| Fiessinger, JN | 1 |
| Ingerman-Wojenski, CM | 1 |
| Silver, MJ | 1 |
| Gelman, JS | 1 |
| Frishman, WH | 1 |
| Miller, KP | 1 |
| Kincaid-Smith, P | 1 |
| Van De Merckt, J | 1 |
| Sneppe, R | 2 |
| Schram, E | 2 |
| Fenollar, JV | 2 |
| Libretti, A | 1 |
| Catalano, M | 1 |
| Fujimoto, T | 1 |
| Yamazaki, H | 1 |
| Valladares, BK | 1 |
| Lemberg, L | 1 |
| Garreyn, S | 1 |
| Ishchenko, MM | 1 |
| Shkrobot, SI | 1 |
| Ishchenko, AM | 1 |
| Verbeuren, TJ | 1 |
| Coene, MC | 1 |
| Jordaens, FH | 1 |
| Van Hove, CE | 1 |
| Zonnekeyn, LL | 1 |
| Herman, AG | 1 |
| Di Perri, T | 1 |
| Plate, G | 1 |
| Stanson, AW | 1 |
| Hollier, LH | 1 |
| Dewanjee, MK | 1 |
| Brewster, DC | 1 |
| Okada, RD | 1 |
| Strauss, HW | 1 |
| Abbott, WM | 1 |
| Darling, RC | 1 |
| Boucher, CA | 1 |
| Grunwald, J | 1 |
| Haft, JI | 1 |
| Gershengorn, K | 1 |
| Kranz, PD | 1 |
| Oestreicher, R | 1 |
| Schnetzer, GW | 1 |
| Penner, JA | 1 |
| Howenstine, JA | 1 |
| Slaton, P | 1 |
| Spitalny, A | 1 |
| Lee, J | 1 |
| Dziewolska, M | 1 |
| Krug, H | 1 |
| Goto, Y | 1 |
| Nishino, T | 1 |
| Cuéllar Suárez, A | 1 |
| García Sánchez, J | 1 |
| Perlick, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation in High Risk Primary Prevention (Patients With Metabolic Syndrome)[NCT00272311] | Phase 4 | 70 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation & Endothelial Function in Secondary Prevention (Pts w/Chronic Stable Coronary Disease)[NCT00272337] | Phase 4 | 37 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Changes in Heme oxygenase (HO-1) a downstream target of nitric oxide (NO) formation. (NCT00272311)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| Arm 1 of 5 Randomized Treatment Arms | 27.6 |
| Arm 2 of 5 Randomized Treatment Arms | 27.0 |
| Arm 3 of 5 Randomized Treatment Arms | 31.4 |
| Arm 4 of 5 Randomized Treatment Arms | 25.7 |
| Arm 5 of 5 Randomized Treatment Arms | 28.3 |
Heme oxygenase a downstream target of nitric oxide formation (NCT00272337)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| 1 of 5 Randomized Treatment Arms | 10.0 |
| 2 of 5 Randomized Treatment Arms | 11.2 |
| 3 of 5 Randomized Treatment Arms | 10.0 |
| 4 of 5 Randomized Treatment Arms | 11.0 |
| 5 of 5 Randomized Treatment Arms | 9.6 |
25 reviews available for dipyridamole and Arteriosclerosis
| Article | Year |
|---|---|
Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.
Topics: Anastomosis, Surgical; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vas | 2015 |
[Platelet inhibitors: old and new].
Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyrid | 2002 |
Antiplatelet agents in atherothrombotic diseases.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Humans; Ischemia; Platelet Aggregation Inhibit | 2004 |
Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Topics: Administration, Oral; Angina Pectoris; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clopido | 2004 |
[Update on antithrombotic treatments in arterial diseases].
Topics: Abciximab; Antibodies, Monoclonal; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Eptifiba | 2007 |
[Antiplatelet and anticoagulant treatment after percutaneous transluminal angioplasty for peripheral arteriosclerosis. Survey of a Cochrane review].
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Dipyridamole; Evidence-Based Medici | 2007 |
Platelets, carotids, and coronaries. Critique on antithrombotic role of antiplatelet agents, exercise, and certain diets.
Topics: Angina Pectoris; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Carotid Artery Thrombosi | 1984 |
[Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Humans; Platelet Aggrega | 1982 |
When do vascular surgeons prescribe antiplatelet therapy? Current attitudes.
Topics: Angioplasty, Balloon; Arteriosclerosis; Aspirin; Dipyridamole; Graft Occlusion, Vascular; Humans; Is | 1993 |
[Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Topics: Adenosine Diphosphate; Adrenergic beta-Antagonists; Analgesics; Anti-Inflammatory Agents; Arterioscl | 1976 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Role of platelets in the proliferative response of the injured artery.
Topics: Animals; Arteries; Arteriosclerosis; Blood Platelets; Cell Differentiation; Cell Survival; Dipyridam | 1978 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agent | 1979 |
Platelet and fibrinogen kinetic evaluation of thrombogenesis.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Platelets; Cell Survival; Dipyridamole; F | 1979 |
[Prophylactic value of platelet anti-aggregants in coronary disease].
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Clofibrate; Coronary Disease; Dipyridamole; Embolism; Hea | 1979 |
[Prospects of antiaggregant therapy in prevention of atherosclerosis].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation Diso | 1979 |
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platele | 1979 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Role of the platelet in atherogenesis.
Topics: Animals; Aorta; Arteriosclerosis; Blood Platelets; Cell Survival; Dipyridamole; Endothelium; Haplorh | 1976 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Platelets and prostaglandins in sudden death: therapeutic implications.
Topics: Adrenergic beta-Antagonists; Animals; Arachidonic Acid; Arachidonic Acids; Arteriosclerosis; Aspirin | 1985 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials a | 1986 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
Coronary artery bypass grafting. A model for the understanding of the progression of atherosclerotic disease and the role of pharmacological intervention.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Collagen; Coronary Artery Bypass | 1985 |
[Thrombosis in various diseases: arteriosclerosis and thrombosis].
Topics: Animals; Arteriosclerosis; Aspirin; Dipyridamole; Humans; Sulfinpyrazone; Thrombosis | 1986 |
14 trials available for dipyridamole and Arteriosclerosis
| Article | Year |
|---|---|
Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
Topics: Adult; Arteriosclerosis; Aspirin; Biomarkers; Blood Platelets; Brain Ischemia; C-Reactive Protein; C | 2006 |
[Controlled cooperative trial of secondary prevention of cerebral ischemic accidents caused by atherosclerosis, using aspirin and dipyridamole].
Topics: Aged; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Dipyridamole; | 1983 |
[Role of antiplatelet agents in the prevention of cerebral ischemic accidents].
Topics: Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; C | 1983 |
Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Disease; Dip | 1983 |
[Aggregation inhibitors or anticoagulants in the prevention of peripheral arterial occlusive diseases].
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Clinical Trials as Topic; Dipyr | 1982 |
Series on pharmacology in practice. 10. Antithrombotic therapy: role of platelet-inhibitor drugs. III. Management of arterial thromboembolic and atherosclerotic disease (third of three parts).
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Cerebrovascular Disorders; Clinical Trials as Topic; Coro | 1981 |
The relationship between the degradation of prostacyclin in blood and antiplatelet drug effects in patients with atherosclerosis.
Topics: Arteriosclerosis; Dipyridamole; Double-Blind Method; Epoprostenol; Humans; Kinetics; Middle Aged; Ni | 1993 |
[Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors].
Topics: Arteriosclerosis; Aspirin; Brain Ischemia; Cerebrovascular Disorders; Dipyridamole; Dose-Response Re | 1996 |
Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Cerebrovascular Disorders; Clinical Trials as Topic; Clo | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Indobufen versus dipyridamole plus aspirin in the treatment of patients with peripheral atherosclerotic disease.
Topics: Aged; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Isoindoles | 1992 |
Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination.
Topics: Adenosine Diphosphate; Arteriosclerosis; Aspirin; Collagen; Dipyridamole; Double-Blind Method; Epine | 1992 |
Platelets and antiplatelet therapy in ischemic heart disease.
Topics: Angina Pectoris; Angioplasty, Balloon; Arteriosclerosis; Aspirin; Blood Platelets; Clinical Trials a | 1986 |
Treatment of claudication with dipyridamole and aspirin.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Dipyridamole; Drug Therapy, Combin | 1986 |
68 other studies available for dipyridamole and Arteriosclerosis
| Article | Year |
|---|---|
Update on the use of antiplatelet agents in secondary stroke prevention.
Topics: Arteriosclerosis; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Embolism, Cholester | 2007 |
[Inhibitors of thrombocytic function for prophylaxis of coronary heart disease (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anticoagulants; Arteriosclerosis; Aspirin; Coronary Diseas | 1982 |
Pharmacology of angioplasty and intravascular thrombolysis.
Topics: Angioplasty, Balloon; Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Dextrans; Dipyrida | 1982 |
Heritable alpha 2-macroglobulin deficiency in a patient with arterial thrombosis: alpha 2-macroglobulin deficiency Irvine.
Topics: alpha-Macroglobulins; Arteriosclerosis; Aspirin; Dipyridamole; Female; Gangrene; Humans; Immunoelect | 1984 |
[Changes in mucopolysaccharides and ultrastructural alterations in experimental atheromatosis].
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Diet, Atherogenic; Dipyridamole; Endothelium; Fibrinolyti | 1982 |
[Therapy of peripheral arterial occlusive diseases. Round table conference].
Topics: Alprostadil; Angioplasty, Balloon; Anti-Bacterial Agents; Anticoagulants; Arterial Occlusive Disease | 1983 |
Effect of antiplatelet therapy on restenosis after experimental angioplasty.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Iliac Arter | 1984 |
Atherosclerosis and cerebral ischemic attacks: intakes of cerebrography with xenon133 inhaled and platelet tests in the diagnosis, clinical and therapeutic monitoring; the preventive role of dipyridamole.
Topics: Adult; Aerosols; Aged; Arteriosclerosis; Dipyridamole; Female; Humans; Ischemic Attack, Transient; M | 1984 |
[Aspirin and dipyridamol or preventive diet].
Topics: Arteriosclerosis; Aspirin; Dietary Fats; Dipyridamole; Humans; Platelet Aggregation; Prostanoic Acid | 1984 |
Abnormalities of lipid metabolism and methods of their correction in patients with glomerulonephritis.
Topics: Adolescent; Adult; Arteriosclerosis; Clofibrate; Dipyridamole; Female; Glomerulonephritis; Humans; H | 1984 |
Effect of prolonged treatment with acetylsalicylic acid and dipyridamole on platelet thromboxane A2 production in atherosclerotic subjects.
Topics: Aged; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Female; Humans; Kinetics; Male; Thro | 1983 |
Non-steroidal anti-inflammatory agents and coronary heart disease.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Caroti | 1980 |
Significance of platelet function and thromboxane B2 levels across the human myocardial vascular bed.
Topics: Arteriosclerosis; Aspirin; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; H | 1981 |
[Platelet aggregation inhibitors].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Dipyridamole; Humans; Platelet Aggregatio | 1981 |
Prevention of lipid accumulation in experimental vein bypass grafts by antiplatelet therapy.
Topics: Animals; Arteriosclerosis; Aspirin; Coronary Artery Bypass; Dipyridamole; Hyperlipidemias; Lipid Met | 1982 |
Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model.
Topics: Animals; Arteriosclerosis; Cyclosporins; Dipyridamole; Drug Therapy, Combination; Graft Rejection; H | 1981 |
Antiplatelet therapy.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprost | 1981 |
Platelets and coronary heart disease: therapy update.
Topics: Arteriosclerosis; Aspirin; Blood Platelets; Coronary Disease; Dipyridamole; Epoprostenol; Hemostasis | 1982 |
Dietary and pharmacologic control of atherosclerosis regression in cynomolgus macaques (Macaca fascicularis).
Topics: Animals; Antihypertensive Agents; Aorta; Arteriosclerosis; Aspirin; Cholesterol; Cholesterol, Dietar | 1981 |
[Effect of dipyridamole on various rheological properties of the blood in arteriosclerosis].
Topics: Adult; Aged; Arteriosclerosis; Blood Viscosity; Dipyridamole; Erythrocyte Aggregation; Female; Human | 1981 |
The effect of low-dose aspirin and dipyridamole upon atherosclerosis in the rabbit.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Female | 1981 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; | 1980 |
Prediction of early cardiac morbidity and mortality following aorto-iliac reconstruction: comparison between clinical scoring systems, echocardiography and dipyridamole-thallium scanning.
Topics: Aged; Aged, 80 and over; Aortic Diseases; Arteriosclerosis; Cause of Death; Dipyridamole; Echocardio | 1995 |
Usefulness of dipyridamole-thallium imaging in 257 patients with atherosclerotic vascular disease.
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Dissection; A | 1995 |
Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Arteriosclerosis; Coronary Disease; Coronary Vessels; Dipyridamole; | 2000 |
The isoproterenol stress test in unanesthetized atherosclerotic rabbits.
Topics: Animals; Arteriosclerosis; Coronary Disease; Dipyridamole; Disease Models, Animal; Electrocardiograp | 1978 |
Studies on the progression and regression of coronary and peripheral atherosclerosis in the cynomolgus monkey. I. Effects of dipyridamole and aspirin.
Topics: Animals; Aorta; Arteries; Arteriosclerosis; Aspirin; Calcium; Cholesterol; Cholesterol, Dietary; Col | 1979 |
Effects of dipyridamole in experimental atherosclerosis. Action on PGI2, platelet aggregation and atherosclerotic plaque formation.
Topics: Adenosine; Animals; Aorta; Arteriosclerosis; Blood Platelets; Culture Techniques; Cyclic AMP; Dipyri | 1979 |
Effects of dipyridamole in vivo on ATP and cAMP content in platelets and arterial walls and on atherosclerotic plaque formation.
Topics: Adenosine Triphosphate; Animals; Aorta; Arteries; Arteriosclerosis; Blood Platelets; Cyclic AMP; Dip | 1979 |
Pathophysiology and medical management of angina pectoris.
Topics: Angina Pectoris; Arteriosclerosis; Coronary Circulation; Coronary Vessels; Dipyridamole; Humans; Nit | 1977 |
[The clofibrate-dipyridamole combination in the treatment of athero-arteriosclerotic vasculopathy].
Topics: Adult; Aged; Arteriosclerosis; Clofibrate; Coronary Disease; Dipyridamole; Drug Combinations; Drug E | 1979 |
Inhibitors of platelet function and atherogenesis.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Disease Models, Animal; Humans; P | 1979 |
[Correction of disorders of rheologic properties of blood in reconstructive operations on the abdominal aorta].
Topics: Adult; Aged; Aorta, Abdominal; Aortic Diseases; Arteriosclerosis; Aspirin; Blood Viscosity; Dipyrida | 1978 |
Platelet survival time: its measurement and use.
Topics: Anti-Inflammatory Agents; Arteriosclerosis; Blood Platelets; Cell Survival; Dipyridamole; Heparin; H | 1978 |
Antithrombotic therapy. Rationale and application.
Topics: Anticoagulants; Arteries; Arteriosclerosis; Aspirin; Blood Coagulation; Blood Coagulation Factors; D | 1979 |
Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.
Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Platelets; Cell Division; Cell Survival; | 1976 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; En | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; En | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; En | 1977 |
Platelets, thrombosis and atherosclerosis.
Topics: Arteries; Arteriosclerosis; Aspirin; Blood Platelets; Cell Division; Cell Survival; Dipyridamole; En | 1977 |
The effect of antiplatelet therapy on platelet accumulation after experimental angioplasty in the rabbit iliac model.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Aspirin; Dipyridamole; Disease Models, Animal; Drug | 1992 |
[The usefulness of dipyridamole stress myocardial scintigram as a preoperative test for detecting ischemic heart disease before vascular surgery].
Topics: Aged; Aged, 80 and over; Aortic Aneurysm, Abdominal; Arteriosclerosis; Dipyridamole; Female; Heart; | 1992 |
[Usefulness of 201Tl myocardial scintigraphy after dipyridamole infusion in patients with atherosclerotic vascular disease].
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Coronary Disease; Dipyridamole; Female; Heart; Humans; In | 1992 |
Effect of buflomedil, dipyridamole and indobufene on hemorrheologic and blood coagulation parameters in patients who underwent vascular surgery for severe atherosclerosis.
Topics: Arteriosclerosis; Blood Coagulation; Blood Viscosity; Dipyridamole; Female; Humans; Isoindoles; Male | 1991 |
[Duplex procedure in prevention of arteriosclerosis].
Topics: Adult; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Female; Humans; Hypolipid | 1991 |
[Early detection and modification of preclinical arteriosclerosis].
Topics: Anticholesteremic Agents; Arteriosclerosis; Aspirin; Dipyridamole; Drug Therapy, Combination; Endoth | 1990 |
Human equivalent doses of platelet inhibitors and experimental atherosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Blood Platelets; Dipyridamole; Dose-Response Relationship | 1990 |
Spontaneous atherosclerotic lesions and prostacyclin formation in rabbits: effects of combined dipyridamole and aspirin.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Arteries; Arteriosclerosis; Aspirin; Dipyridamole; Dru | 1989 |
Thrombus formation on the aorta injured by angioplasty and its prevention with dilazep in atherosclerotic rabbits.
Topics: Angioplasty, Balloon; Animals; Aorta; Arteriosclerosis; Azepines; Body Weight; Cholesterol; Dilazep; | 1989 |
[Role of myocardium scintigraphy with thallium dipyridamole in the evaluation of arterial disease of the legs].
Topics: Adult; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Arteriosclerosis; Dipyridamole; Female; | 1989 |
Model system to study interaction of platelets with damaged arterial wall. II. Inhibition of smooth muscle cell proliferation by dipyridamole and AH-P719.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Arteries; Arteriosclerosis; Aspirin; Blood Platelets; | 1988 |
Prevention of kidney arteriosclerosis: heparin, dipyridamole, warfarin, and plasma exchange.
Topics: Arteriosclerosis; Biopsy; Dipyridamole; Graft Rejection; Heparin; Humans; Kidney; Kidney Glomerulus; | 1987 |
Platelet hyperaggregability, blood prostacyclin and dipyridamole.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Arteriosclerosis; Binding Sites; Dipyridamole; Drug Admin | 1986 |
Platelet aggregation and atherosclerosis.
Topics: Arteriosclerosis; Aspirin; Dipyridamole; Electrocardiography; Humans; Male; Middle Aged; Myocardial | 1986 |
Glucose and erythrocyte ATP: distinctive effects of dipyridamole and of ticlopidine.
Topics: Adenosine; Adenosine Triphosphate; Arteriosclerosis; Blood Glucose; Dipyridamole; Drug Therapy, Comb | 1987 |
[Curantyl treatment of patients with atherosclerosis and chronic cerebral circulatory insufficiency].
Topics: Adult; Aged; Arteriosclerosis; Cerebrovascular Disorders; Dipyridamole; Female; Humans; Male; Middle | 1986 |
Effect of hypercholesterolemia on vascular reactivity in the rabbit. II. Influence of treatment with dipyridamole on endothelium-dependent and endothelium-independent responses in isolated aortas of control and hypercholesterolemic rabbits.
Topics: Animals; Aorta; Arteriosclerosis; Body Weight; Cholesterol; Cholesterol, Dietary; Dipyridamole; Hype | 1986 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; D | 1985 |
Drug effects on platelet deposition after endothelial injury of the rabbit aorta.
Topics: Animals; Aorta; Arteriosclerosis; Aspirin; Dipyridamole; Endothelium; Epoprostenol; Ibuprofen; Plate | 1985 |
Selection of patients for preoperative coronary angiography: use of dipyridamole-stress--thallium myocardial imaging.
Topics: Aged; Arteriosclerosis; Coronary Angiography; Coronary Disease; Dipyridamole; Exercise Test; Female; | 1985 |
The influence of antiplatelet drugs on injury-stimulated migration of cultured smooth muscle cells.
Topics: Animals; Arteriosclerosis; Aspirin; Catheterization; Cell Movement; Cells, Cultured; Dipyridamole; H | 1985 |
The influence of nitroglycerin and dipyridamole on pacing-induced S-T segment depression in unanesthetized, atherosclerotic rabbits.
Topics: Angina Pectoris; Animals; Arteriosclerosis; Cholesterol, Dietary; Dipyridamole; Dose-Response Relati | 1973 |
Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation.
Topics: Animals; Arteriosclerosis; Aspirin; Catecholamines; Dipyridamole; Dogs; Epinephrine; Heart; Myocardi | 1972 |
Chronic intravascular coagulation syndrome associated with atherosclerotic aortic aneurysm.
Topics: Aged; Aortic Aneurysm; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Chronic Disease | 1973 |
Flank pain and hematuria in a young man with renal artery arteriosclerosis: remission of symptoms during administration of dipyridamole.
Topics: Adult; Angiography; Arteriosclerosis; Dipyridamole; Hematuria; Hemorrhage; Humans; Ischemia; Kidney; | 1974 |
[Role of thrombotic agent in coronary insufficiency--therapeutic implications (author's transl)].
Topics: Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelet Disorders; Coronary Disease; | 1974 |
Arterial and venous thromboembolism: kinetic characterization and evaluation of therapy.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Cell Count; Blood Platelets; Dipyridamole; Drug Synerg | 1974 |
[Arteriosclerosis].
Topics: Adult; Aged; Arteriosclerosis; Cholestyramine Resin; Diet Therapy; Dipyridamole; Humans; Hyperlipide | 1971 |
[Studies on platelet adhesiveness. II. On various diseases].
Topics: Adenosine; Arteriosclerosis; Dextrans; Diabetes Mellitus; Dipyridamole; Female; Fibrinolytic Agents; | 1970 |
[Tonographic changes caused by dipyridamol].
Topics: Aqueous Humor; Arteriosclerosis; Dipyridamole; Eye Diseases; Humans; Injections, Intravenous; Intrao | 1969 |
[Thrombophilia in early and late sclerosis].
Topics: Age Factors; Anticoagulants; Arteries; Arteriosclerosis; Dipyridamole; Humans; Lipid Metabolism; Nuc | 1968 |